tiprankstipranks
Nu-Med Plus Inc (NUMD)
OTHER OTC:NUMD
US Market

Nu-Med Plus (NUMD) Stock Price & Analysis

1 Followers

NUMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.09
Previous Close$0.07
Volume122.00K
Average Volume (3M)67.85K
Market Cap
$3.55M
Enterprise Value$3.65M
Total Cash (Recent Filing)$6.81K
Total Debt (Recent Filing)$100.00K
Price to Earnings (P/E)-44.0
Beta0.80
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding83,548,469
10 Day Avg. Volume22,385
30 Day Avg. Volume67,851
Standard Deviation0.38
R-Squared0.02
Alpha0.00526
Financial Highlights & Ratios
Price to Book (P/B)-23.49
Price to Sales (P/S)-1149.07
Price to Cash Flow (P/CF)-201.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.22K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda1.79K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

16.04%0.00%0.00%83.96%
16.04% Insiders
0.00% Other Institutional Investors
83.96% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

NUMD FAQ

What was Nu-Med Plus Inc’s price range in the past 12 months?
Nu-Med Plus Inc lowest stock price was <$0.01 and its highest was $0.09 in the past 12 months.
    What is Nu-Med Plus Inc’s market cap?
    Currently, no data Available
    When is Nu-Med Plus Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Nu-Med Plus Inc’s earnings last quarter?
    Currently, no data Available
    Is Nu-Med Plus Inc overvalued?
    According to Wall Street analysts Nu-Med Plus Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Nu-Med Plus Inc pay dividends?
      Nu-Med Plus Inc does not currently pay dividends.
      What is Nu-Med Plus Inc’s EPS estimate?
      Nu-Med Plus Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Nu-Med Plus Inc have?
      Nu-Med Plus Inc has 83,548,470 shares outstanding.
        What happened to Nu-Med Plus Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Nu-Med Plus Inc?
        Currently, no hedge funds are holding shares in NUMD
        ---

        Nu-Med Plus Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Positive
        20 days / 200 days
        Momentum
        156.25%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        2.76%
        Trailing 12-Months

        Company Description

        Nu-Med Plus Inc

        Nu-Med Plus, Inc. engages in the development, manufacture, and marketing of technologies utilizing nitric oxide in the medical device field. It includes nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company was founded on October 19, 2011 and is headquartered in Salt Lake City, UT.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        PAVmed
        Abeona Therapeutics
        Curis
        Neurometrix
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis